MEASURING HEALTH-RELATED QUALITY OF LIFE BY EXPERIENCES

Published Apr 10, 2015
Maastricht, The Netherlands - For values of health-related quality of life to be useful in policy, it is crucial that these are measured accurately. Instruments to obtain patient valuations of their own health-related quality of life (HRQOL) usually rely on retrospective self-report. However, due to imperfect recollection of past experiences, these self-reports only partially capture the impact of health problems on the daily lives of people who are affected. In the study “Measuring Health-Related Quality of Life by Experiences: The Experience Sampling Method,” a group of researchers from Maastricht University and the European Centre for Environment and Human Health of the University of Exeter explored the feasibility of measuring HRQOL from moment to moment, in the context of daily life by using the Experience Sampling Method (ESM). They also examined the relationships between momentary feelings and symptoms and valuation of HRQOL and retrospective valuation of HRQOL. The main results of the study showed that the use of the ESM to measure accounts of the momentary experience of health in different populations is feasible. Furthermore, momentary feelings and symptoms were significant predictors of momentary HRQOL, but not of retrospective HRQOL. The authors point out that, “This study highlights that retrospective measures may provide a biased account of the impact of health problems in the daily lives of people who are affected. Therefore ESM may provide a valuable addition to the measurement of HRQOL.”

Related Stories

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.

Listening to Patients in the Real World

Jun 23, 2026

Value in Health, the official journal of ISPOR announced today the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies.

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×